Company / Capital Expenditures
Doximity Capital Expenditures History
FY2019-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Capital Expenditures
-
FY2024
5-year range
$0 / $1.9M
FY2020-FY2024
Trend
-100.0%
vs FY2023
Sector context
#146 of 145
Health Care
What the data says
Declined from $2M to $0 over the past 2 years.
Health Care sector context is included.
Capital Expenditures over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom -1% in Health CareTop 101% of 145
▼
Key checks
Key Insights
- Doximity's capital expenditures has declined for 3 consecutive years.
- In FY2024, capital expenditures decreased 100.0% year-over-year.
- Peak capital expenditures was recorded in FY2021.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score 3.16 (safe zone, above 2.9 threshold)
- Strong profit margin: 39.1%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Capital ExpendituresValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | $0 | -100.0% |
| FY2023 | $147.0K | -91.4% |
| FY2022 | $1.7M | -11.0% |
| FY2021 | $1.9M | +680.4% |
| FY2020 | $245.0K | -14.0% |
| FY2019 | $285.0K | - |
As of FY2024 · SEC 10-K · Updated Mar 29, 2026